Expertise in
15
conditions

Dr. Patrick B. Johnston

Orthopedics
Steamboat Orthopaedic And Spine Institute
705 Marketplace Plaza, Suite 100, 
Steamboat Springs, CO 
Accepting New Patients
17 Years of Experience
Referral may be required
Expertise in
15
conditions
Steamboat Orthopaedic And Spine Institute
705 Marketplace Plaza, Suite 100, 
Steamboat Springs, CO 

Overview

Patrick Johnston is an Orthopedics provider practicing medicine in Steamboat Springs, Colorado. He has been practicing medicine for over 17 years.

Dr. Johnston is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Rhizarthrosis, Ganglion Cyst, Carpal Tunnel Syndrome, Vitrectomy, and Tissue Biopsy.

He is actively involved in clinical research, co-authoring 161 peer reviewed articles and participating in 9 clinical trials. Dr. Johnston is currently accepting new patients.

Graduate Year

2009

Specialties

Orthopedics

Licenses

Hand Surgery in CO

Hospital Affiliations

Sidney Regional Medical Center
Box Butte General Hospital
Morrill County Community Hospital
The Memorial Hospital
Uchealth Yampa Valley Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

Steamboat Orthopaedic and Spine Institute
705 Marketplace Plaza, Suite 100, Steamboat Springs, CO 80487

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Randomized Double-Blind Phase III Study of Ibrutinib During and Following Autologous Stem Cell Transplantation Versus Placebo in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma of the Activated B-Cell Subtype
A Randomized Double-Blind Phase III Study of Ibrutinib During and Following Autologous Stem Cell Transplantation Versus Placebo in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma of the Activated B-Cell Subtype
Enrollment Status: Active_not_recruiting
Publish Date: July 31, 2026
Intervention Type: Drug, Other, Procedure
Study Drugs: Carmustine, Cyclophosphamide, Cytarabine, Etoposide, Ibrutinib, Melphalan
Study Phase: Phase 3
A Phase 2 Study of Nivolumab and Brentuximab Vedotin Consolidation After Autologous Stem Cell Transplantation in Patients With High-Risk Classical Hodgkin Lymphoma
A Phase 2 Study of Nivolumab and Brentuximab Vedotin Consolidation After Autologous Stem Cell Transplantation in Patients With High-Risk Classical Hodgkin Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: May 01, 2026
Intervention Type: Drug, Biological, Other
Study Drugs: Brentuximab, Nivolumab
Study Phase: Phase 2
A Randomized Phase II Trial of Myeloablative Versus Non-Myeloablative Consolidation Chemotherapy for Newly Diagnosed Primary CNS B-cell Lymphoma
A Randomized Phase II Trial of Myeloablative Versus Non-Myeloablative Consolidation Chemotherapy for Newly Diagnosed Primary CNS B-cell Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: January 30, 2026
Intervention Type: Drug, Procedure
Study Drugs: Carmustine, Cytarabine, Etoposide, Thiotepa, Granulocyte Colony-Stimulating Factor
Study Phase: Phase 2
A Phase 3, Randomized, Open-Label Study Evaluating the Efficacy of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Subjects With Relapsed/Refractory Diffuse Large B Cell Lymphoma (ZUMA-7)
A Phase 3, Randomized, Open-Label Study Evaluating the Efficacy of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Subjects With Relapsed/Refractory Diffuse Large B Cell Lymphoma (ZUMA-7)
Enrollment Status: Completed
Publish Date: December 01, 2025
Intervention Type: Biological, Drug
Study Drugs: Axicabtagene Ciloleucel, Platinum-containing salvage chemotherapy (eg, R-ICE) followed by high dose therapy (eg, BEAM) and autologous stem cell transplant in responders, Cyclophosphamide, Fludarabine
Study Phase: Phase 3
A Phase 2 Front-Line PET/CT-2 Response-Adapted Brentuximab Vedotin and Nivolumab Incorporated and Radiation-Free Management of Early Stage Classical Hodgkin Lymphoma (cHL)
A Phase 2 Front-Line PET/CT-2 Response-Adapted Brentuximab Vedotin and Nivolumab Incorporated and Radiation-Free Management of Early Stage Classical Hodgkin Lymphoma (cHL)
Enrollment Status: Active_not_recruiting
Publish Date: November 06, 2024
Intervention Type: Other, Drug, Biological
Study Drugs: Bleomycin, Brentuximab, Dacarbazine, Doxorubicin, Nivolumab, Vinblastine
Study Phase: Phase 2
A Phase 3, Randomized, Open-Label, Multicenter Study Comparing the Efficacy and Safety of the Bruton's Tyrosine Kinase (BTK) Inhibitors BGB-3111 and Ibrutinib in Subjects With Waldenström's Macroglobulinemia (WM)
A Phase 3, Randomized, Open-Label, Multicenter Study Comparing the Efficacy and Safety of the Bruton's Tyrosine Kinase (BTK) Inhibitors BGB-3111 and Ibrutinib in Subjects With Waldenström's Macroglobulinemia (WM)
Enrollment Status: Completed
Publish Date: October 26, 2024
Intervention Type: Drug
Study Drugs: BGB-3111 (Zanubrutinib), Ibrutinib
Study Phase: Phase 3
Phase 1/2 Study of TAK-981 in Combination With Rituximab in Patients With Relapsed/Refractory CD20-Positive Non-Hodgkin Lymphoma
Phase 1/2 Study of TAK-981 in Combination With Rituximab in Patients With Relapsed/Refractory CD20-Positive Non-Hodgkin Lymphoma
Enrollment Status: Terminated
Publish Date: June 14, 2024
Intervention Type: Drug
Study Drugs: TAK-981, Rituximab
Study Phase: Phase 1/Phase 2
Phase I Clinical Trial for Evaluation of Nivolumab and Pomalidomide Combination for Relapsed/Refractory Primary Central Nervous System Lymphoma and Primary Vitreoretinal Lymphoma
Phase I Clinical Trial for Evaluation of Nivolumab and Pomalidomide Combination for Relapsed/Refractory Primary Central Nervous System Lymphoma and Primary Vitreoretinal Lymphoma
Enrollment Status: Completed
Publish Date: January 06, 2023
Intervention Type: Drug, Biological
Study Drugs: Nivolumab, Pomalidomide
Study Phase: Phase 1
Phase 1 Study of Everolimus in Combination With Brentuximab Vedotin in Patients With Relapsed or Refractory Hodgkin Lymphoma
Phase 1 Study of Everolimus in Combination With Brentuximab Vedotin in Patients With Relapsed or Refractory Hodgkin Lymphoma
Enrollment Status: Terminated
Publish Date: December 12, 2019
Intervention Type: Drug, Other
Study Phase: Phase 1
View 8 Less Clinical Trials

161 Total Publications

Circulating Tumor DNA Assessment of Disease Response in Large B-Cell Lymphoma: Lisocabtagene Maraleucel Versus Autologous Stem Cell Transplantation Standard Therapy.
Circulating Tumor DNA Assessment of Disease Response in Large B-Cell Lymphoma: Lisocabtagene Maraleucel Versus Autologous Stem Cell Transplantation Standard Therapy.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 27, 2026
Similar Doctors
Expertise in
14
conditions
Expertise in
14
conditions
Referral may be required

Steadman Clinic Professional LLC

181 W Meadow Dr Ste 400, 
Vail, CO 
 (88.9 miles away)
970-476-1100
Languages Spoken:
English
See accepted insurances

Peter Millett is an Orthopedics provider practicing medicine in Vail, Colorado. Dr. Millett is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Tendinitis, Hypermobile Joints, Osteoarthritis, Tenotomy, and Endoscopy.

Expertise in
11
conditions
Expertise in
11
conditions
Referral may be required
Before you request

Steamboat Orthopaedic And Spine Institute

705 Marketplace Plaza, Suite 100, 
Steamboat Springs, CO 
 (40.2 miles away)
970-879-6663
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Andreas Sauerbrey is an Orthopedics provider practicing medicine in Steamboat Springs, Colorado. Dr. Sauerbrey is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Osteoarthritis, Synovial Osteochondromatosis, Tendinitis, Carpal Tunnel Syndrome, and Hip Replacement. Dr. Sauerbrey is currently accepting new patients.

Expertise in
8
conditions
Expertise in
8
conditions
Referral may be required
Before you request

Steamboat Orthopaedic And Spine Institute

705 Marketplace Plaza, Suite 100, 
Steamboat Springs, CO 
 (40.2 miles away)
970-879-6663
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Alexander Meininger is an Orthopedics provider practicing medicine in Steamboat Springs, Colorado. Dr. Meininger is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Osteoarthritis, Synovial Osteochondromatosis, Tendinitis, and Baker Cyst. Dr. Meininger is currently accepting new patients.

Frequently Asked Questions about Dr. Patrick B. Johnston

How do I make an appointment with Dr. Patrick B. Johnston?

You can book an appointment with Dr. Patrick B. Johnston by calling their office at 970-879-6663. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Patrick B. Johnston a top-rated expert for Rhizarthrosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Patrick B. Johnston is classified as an Distinguished expert for Rhizarthrosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Patrick B. Johnston specialize in?

While Dr. Patrick B. Johnston is a Orthopedics, they have specific expertise in Rhizarthrosis, Ganglion Cyst, and Carpal Tunnel Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Orthopedics.

Does Dr. Patrick B. Johnston participate in research or clinical trials?

Yes. Dr. Patrick B. Johnston has published 161 articles and abstracts on conditions like Rhizarthrosis. You can view a list of Dr. Patrick B. Johnston's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Patrick B. Johnston accept my insurance?

Dr. Patrick B. Johnston accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 970-879-6663 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Johnston's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 20 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile